1 |
Anti-CRISPR Proteins: Applications in Genome EngineeringLee, Jooyoung 14 July 2020 (has links)
Clustered, regularly interspaced, short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) constitute a bacterial and archaeal adaptive immune system. The ongoing arms race between prokaryotic hosts and their invaders such as phages led to the emergence of anti-CRISPR proteins as countermeasures against the potent antiviral defense. Since the first examples of anti-CRISPRs were shown in a subset of CRISPR-Cas systems, we endeavored to uncover these naturally-occurring inhibitors that inactivate different types of CRISPR-Cas systems. In the first part of my thesis, we have identified and characterized Type II anti-CRISPR proteins that inactivate several Cas9 orthologs. We share mechanistic insights into anti-CRISPR inhibition and show evidence of its potential utility as an off-switch for Cas9-mediated mammalian genome editing. Although the RNA programmability of Cas9 enables facile genetic manipulation with great potential for biotechnology and therapeutics, limitations and safety issues remain. The advent of anti-CRISPR proteins presents opportunities to exploit the inhibitors to exert temporal, conditional, or spatial control over CRISPR. In the second part of my thesis, we demonstrate that anti-CRISPR proteins can serve as useful tools for Cas9 genome editing. In particular, we have demonstrated that anti-CRISPRs are effective as genome editing off-switches in the tissues of adult mammals, and we further engineered anti-CRISPR proteins to achieve tissue-specific editing in vivo. Taken together, my thesis research aimed to mine for natural anti-CRISPR protein inhibitors and repurpose these proteins to complement current Cas9 technologies in basic and clinical research.
|
2 |
<b>Insights into the Molecular Interactions of Anti-CRISPR Proteins in Bacteria to Evade CRISPR-Cas Immunity</b>Indranil Arun Mukherjee (19202494) 26 July 2024 (has links)
<p dir="ltr">Anti-CRISPR (Acr) proteins are produced by phages to deactivate CRISPR–Cas systems in bacteria and archaea, thus expanding the CRISPR toolbox for genome editing. In this study, we present the structure and function of AcrIF24, an Acr protein that inhibits the type I-F CRISPR–Cas system in Pseudomonas aeruginosa. AcrIF24 forms a homodimer that binds to two surveillance complexes (Csy), preventing CRISPR RNA from hybridizing with target DNA. Additionally, AcrIF24 acts as an anti-CRISPR-associated (Aca) protein, suppressing the transcription of the acrIF23-acrIF24 operon. Whether alone or in complex with Csy, AcrIF24 binds to the acrIF23-acrIF24 promoter DNA with nanomolar affinity. The 2.7 Å structure of the Csy–AcrIF24–promoter DNA complex reveals how transcriptional suppression occurs. Our findings demonstrate that AcrIF24 functions as an Acr-Aca fusion protein and enhance our understanding of the varied mechanisms employed by Acr proteins.</p><p dir="ltr">In the ongoing evolutionary struggle between bacteria and bacteriophages, the emergence of CRISPR and anti-CRISPR systems has shaped host-pathogen interactions significantly. Bacteriophages exert intense selective pressure on bacteria, driving the evolution of defense mechanisms such as restriction enzymes and the CRISPR-Cas system. Conversely, bacteriophages have evolved anti-CRISPR proteins (Acrs) to counteract CRISPR-Cas-mediated targeting. Here, we investigate the interactions and regulatory mechanisms within co-encoded Acrs, focusing on AcrVA1-5 from a prophage within Moraxella bovoculi. Our findings reveal that AcrVA1 and AcrVA2 form a stable complex capable of inhibiting Cas12a-mediated DNA cleavage, with AcrVA1 regulating the activity of AcrVA2. Additionally, AcrVA4 and AcrVA5 form a complex that modulates Cas12a activity by inhibiting DNA binding and lysin acetylation, respectively. Structural and biochemical analyses uncover a complex regulatory network governing the function of co-encoded Acrs, highlighting their role in downregulating DNA targeting in response to Cas12a presence and aiding the survival of both phage and host bacteria during infection.</p>
|
3 |
The CRISPR-Cas systemStens, Cassandra, Enoksson, Isabella, Berggren, Sara January 2020 (has links)
Derived from and inspired by the adaptive immune system of bacteria, CRISPR has gone from basic biology knowledge to a revolutionizing biotechnological tool, applicable in many research areas such as medicine, industry and agriculture. The full mechanism of CRISPR-Cas9 was first published in 2012 and various CRISPR-Cas systems have already passed the first stages of clinical trials as new gene therapies. The immense research has resulted in continuously growing knowledge of CRISPR systems and the technique seems to have the potential to greatly impact all life on our planet. Therefore, this literature study aims to thoroughly describe the CRISPR-Cas system, and further suggest an undergraduate laboratory exercise involving gene editing with the CRISPR-Cas9 tool. In this paper, we describe the fundamental technical background of the CRISPR-Cas system, especially emphasizing the most studied CRISPR-Cas9 system, its development and applications areas, as well as highlighting its current limitations and ethical concerns. The history of genetic engineering and the discovery of the CRISPR system is also described, along with a comparison with other established gene editing techniques. This study concludes that a deeper knowledge about CRISPR is important and required since the technique is applicable in many research areas. A laboratory exercise will not only inspire but also provide extended theoretical and practical knowledge for undergraduate students.
|
Page generated in 0.0248 seconds